Pages that link to "Q24307374"
Jump to navigation
Jump to search
The following pages link to TrkA alternative splicing: a regulated tumor-promoting switch in human neuroblastoma (Q24307374):
Displaying 50 items.
- Neurotrophic receptor tyrosine kinase 1 (Q4051790) (← links)
- Growth factor receptor bound protein 2 (Q5514416) (← links)
- Phosphoinositide-3-kinase regulatory subunit 1 (Q7119385) (← links)
- Phospholipase C gamma 1 (Q21104742) (← links)
- SHC adaptor protein 1 (Q21116165) (← links)
- Fibroblast growth factor receptor substrate 2 (Q21172873) (← links)
- Cancer-associated splicing variant of tumor suppressor AIMP2/p38: pathological implication in tumorigenesis (Q21563389) (← links)
- Gelatinase B/MMP-9 in Tumour Pathogenesis and Progression (Q24568374) (← links)
- Neuroblastoma-derived secretory protein is a novel secreted factor overexpressed in neuroblastoma (Q24594695) (← links)
- NTRK gene fusions as novel targets of cancer therapy across multiple tumour types (Q28066821) (← links)
- TRKing down an old oncogene in a new era of targeted therapy (Q28254287) (← links)
- Roles for NF-kappaB in nerve cell survival, plasticity, and disease (Q28290234) (← links)
- NTRK1 fusion in glioblastoma multiforme (Q28541127) (← links)
- Small molecule activators of the Trk receptors for neuroprotection (Q33393895) (← links)
- The genome sequence of the protostome Daphnia pulex encodes respective orthologues of a neurotrophin, a Trk and a p75NTR: evolution of neurotrophin signaling components and related proteins in the bilateria (Q33508938) (← links)
- The "neuro" of neuroblastoma: Neuroblastoma as a neurodevelopmental disorder (Q33643120) (← links)
- Hypoxic tumor microenvironment and cancer cell differentiation (Q33670820) (← links)
- Exon array analysis reveals neuroblastoma tumors have distinct alternative splicing patterns according to stage and MYCN amplification status (Q33875892) (← links)
- A truncated human NKG2D splice isoform negatively regulates NKG2D-mediated function. (Q34146619) (← links)
- Hypoxia regulates alternative splicing of HIF and non-HIF target genes. (Q34177914) (← links)
- Trk receptor expression and inhibition in neuroblastomas (Q34549157) (← links)
- Phase I trial of lestaurtinib for children with refractory neuroblastoma: a new approaches to neuroblastoma therapy consortium study (Q34549193) (← links)
- Therapeutic targets for neuroblastomas (Q34560877) (← links)
- Acute myeloid leukemia with the 8q22;21q22 translocation: secondary mutational events and alternative t(8;21) transcripts (Q34578418) (← links)
- Effect of brain- and tumor-derived connective tissue growth factor on glioma invasion (Q35143965) (← links)
- The TrkAIII oncoprotein inhibits mitochondrial free radical ROS-induced death of SH-SY5Y neuroblastoma cells by augmenting SOD2 expression and activity at the mitochondria, within the context of a tumour stem cell-like phenotype (Q35149468) (← links)
- Clinical significance of NTRK family gene expression in neuroblastomas (Q35673178) (← links)
- Novel transcripts reveal a complex structure of the human TRKA gene and imply the presence of multiple protein isoforms (Q35845700) (← links)
- Proteolytic cleavage, trafficking, and functions of nuclear receptor tyrosine kinases (Q36113481) (← links)
- Novel and novel de novo mutations in NTRK1 associated with congenital insensitivity to pain with anhidrosis: a case report (Q36151639) (← links)
- Post-transcriptional regulation in cancer progression : Microenvironmental control of alternative splicing and translation (Q36398266) (← links)
- Role of Matrix Metalloproteinase-2, Matrix Metalloproteinase-9, and Vascular Endothelial Growth Factor in the Development of Chronic Subdural Hematoma (Q36427681) (← links)
- Alternative TrkAIII splicing: a potential regulated tumor-promoting switch and therapeutic target in neuroblastoma. (Q36429595) (← links)
- Alternative splicing variant of the hypoxia marker carbonic anhydrase IX expressed independently of hypoxia and tumour phenotype (Q36608750) (← links)
- Current insights into the regulation of programmed cell death by NF-kappaB. (Q36637900) (← links)
- The dark side of the NGF family: neurotrophins in neoplasias (Q36654494) (← links)
- SPLOOCE: a new portal for the analysis of human splicing variants. (Q36684601) (← links)
- Cytosolic accumulation of gammaH2AX is associated with tropomyosin-related kinase A-induced cell death in U2OS cells (Q37184905) (← links)
- A novel uHPLC-MS/MS method for the quantitation of AZD7451 (AZ12607092) in human plasma (Q37396536) (← links)
- Trk kinase inhibitors as new treatments for cancer and pain (Q37481264) (← links)
- On Trk--the TrkB signal transduction pathway is an increasingly important target in cancer biology (Q37597739) (← links)
- Nerve growth factor signaling in prostate health and disease. (Q37694590) (← links)
- On the death Trk. (Q37699051) (← links)
- Assembly and activation of neurotrophic factor receptor complexes (Q37699060) (← links)
- The connections between neural crest development and neuroblastoma (Q37836006) (← links)
- The molecular profile of microglia under the influence of glioma (Q38008966) (← links)
- Functional multipotency of stem cells: a conceptual review of neurotrophic factor-based evidence and its role in translational research (Q38015343) (← links)
- Mechanisms of neuroblastoma regression (Q38261519) (← links)
- Retrograde TrkAIII transport from ERGIC to ER: a re-localisation mechanism for oncogenic activity. (Q38262750) (← links)
- A genome-wide analysis of the gene expression profiles and alternative splicing events during the hypoxia-regulated osteogenic differentiation of human cartilage endplate-derived stem cells (Q38665856) (← links)